Yüklüyor......
Evaluation of global laboratory methods and establishing on‐therapy ranges for monitoring apixaban and rivaroxaban: Experience at a single institution
BACKGROUND: Apixaban and rivaroxaban are approved for the prevention and treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and embolic stroke in atrial fibrillation (AF) patients. The aim of this study was to find appropriate methods of monitoring the anticoagulant effects of are dir...
Kaydedildi:
| Yayımlandı: | J Clin Lab Anal |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6595315/ https://ncbi.nlm.nih.gov/pubmed/30860622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcla.22869 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|